Business
Coherus BioSciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that its fourth quarter and full
About this update from Coherus Oncology, Inc.
[{"type":"text","content":"REDWOOD CITY, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that its fourth quarter and full year 2022 financial results will be released after market close on Monday, March 6, 2023. Starting at 5:00 pm ET on March 6, 2023, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. A replay of the webcast will be available on http://investors.coherus.com following the conclusion of the live conference call. Conference Call InformationWhen: Monday, March 6th, 2023, starting at 5:00 p.m. Eastern TimeTo access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI8a3cc318d81c4ebaa9d8f6e635f9731c Webcast: https://edge.media-server.com/mmc/p/jcpis3ko The press release with the fourth quarter and full year 2022 financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call. A live and archived webcast will be available on the “Investors” section of the Coherus website at http://investors.coherus.com. Please dial-in 15 minutes early to ensure a timely connection to the call. Coherus Contact Information:Marek Ciszewski, SVP Investor [email protected] \nSource: Coherus BioSciences, Inc.","length":4338,"tagName":"div"}]